CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity-Reference-Cited by-同舟云学术

CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity

Published:2018-12-28 Issue:3 Volume:184 Page:337-347
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Masetti Riccardo¹^ORCID,Bertuccio Salvatore N.¹^ORCID,Pession Andrea¹,Locatelli Franco²^ORCID

Affiliation:

1. Department of Paediatrics; “Lalla Seràgnoli”, Haematology-Oncology Unit; University of Bologna; Bologna Italy

2. Department of Paediatric Haematology-Oncology and Cell and Gene Therapy; IRCCS Ospedale Pediatrico Bambino Gesù, Rome; Sapienza University of Rome; Rome Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Riccardo Masetti

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15725/fullpdf

Reference44 articles.

1. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding;Agyeman;Oncotarget,2014

2. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis;Attanasio;Nature Genetics,2007

3. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions;Bolouri;Nature Genetics,2018

4. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation;Chyla;Molecular and Cellular Biology,2008

5. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity;Creutzig;Leukemia,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients;British Journal of Haematology;2024-07-31

2. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

3. Stratégies préventives et thérapeutiques de la rechute après allogreffe de cellules souches hématopoïétiques pour les LAM pédiatriques (SFGM-TC);Bulletin du Cancer;2024-06

4. CBFA2T3 Is PPARA Sensitive and Attenuates Fasting-Induced Lipid Accumulation in Mouse Liver;Cells;2024-05-13

5. Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse; no longer a pediatric disease;Annals of Hematology;2024-04-27